ent-Voriconazole,
137234-63-0,
(2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol,
188416-29-7,
UNII-1Y58LNV43M,
1Y58LNV43M,
4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaS,betaR)-,
Voriconazole related compound B,
(2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol,
Voriconazole enantiomer,
(2S,3R)-rel-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol,
Voriconazole specified impurity D [EP],
Voriconazole related compound B RS [USP],
ZINC842,
SCHEMBL371715,
Jsp003733,
CTK8E9204,
DTXSID60160114,
BCEHBSKCWLPMDN-HWPZZCPQSA-N,
BCP11125,
AC-8178,
ACN-036097,
KS-00000L06,
AJ-07924,
AK119804,
DS-11148,
AX8245220,
RT-012474,
FT-0675849,
UNII-USG4B1CD29 component BCEHBSKCWLPMDN-HWPZZCPQSA-N,
(|AS,|AR)-|A-(2,4-Difluorophenyl)-5-fluoro-|A-methyl-|A-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol,
(2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol,
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyriMidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (RaceMic Voriconazole),
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol- 1-yl)butan-2-ol,
(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butane-2-ol,
[S-(R*,S*)]-|A-(2,4-Difluorophenyl)-5-fluoro-|A-methyl-|A-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol,
(+/-)-Voriconazole,
Voriconazole USP RC B,
Voriconazole, (+/-)-,
UNII-USG4B1CD29,
Voriconazole related compound A,
Voriconazole related compound A RS [USP],
182230-43-9,
4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-rel-,